ACTalks Blogs

 View Only

Message from ACT Corporate Partner — Inotiv

By Art Shaw posted 09-20-2023 03:00 PM

  
ACT Corporate Partner Message 

Safety Pharmacology Services at Inotiv

Integrated High-Quality In Vivo Services for Safety Evaluations

Safety pharmacology evaluations are essential in assessing acute risks and potential undesirable effects of novel pharmaceuticals as part of IND-enabling programs.

Use our deep expertise in drug safety assessment to your advantage. At Inotiv, our team understands the importance and complexity of the drug development process and will be there to guide you to success by offering an integrated safety pharmacology solution that includes respiratory, central nervous system (CNS), and cardiovascular (CV) evaluations as stand-alone services or as part of a full IND/CTA program.

Gain the insight and expertise you need to progress to your next milestone with Inotiv’s in vivo safety evaluation service offerings, which include:

A FULLY CAPABLE CORE BATTERY OF STUDIES, SUCH AS:

  • CNS — functional observational battery of modified Irwin's
  • Telemetered CV — blood pressure, heart rate, and electrocardiogram studies
  • Respiratory
    • Plethysmography assessments in rodents
    • Large animal tests with CV telemetry (canine and NHP cardiopulmonary telemetry)
  • Regulated or non-regulated services
  • Expertise in surgical procedures

AN INTEGRATED SAFETY PHARMACOLOGY PACKAGE THAT INCLUDES RESPIRATORY, CNS, AND CV STUDIES AS: 

  • Stand-alone services
  • Part of a full IND/CTA program
    • Traditional research models
  • Access to industry leading DSI™ hardware and Ponemah software

0 comments
17 views

Permalink